Roche's core research spans five large areas. Boris Zaïtra, who now leads corporate business development, is confident his ...

Expect more details on Trump’s healthcare agenda in the coming weeks as the Senate vets both Kennedy and Makary. In the meantime, here are few other highlights from BioPharma Dive’s time covering the ...

The clearance broadens use of Omvoh, which is part of a slate of new medicines Lilly is counting on to build on its success ...

Quantum BioPharma (QNTM) will be back in the Ontario Superior Court of Justice on January 24, 2025. Quantum BioPharma is seeking a Court Order declaring Dr. Raza Bokhari, current CEO of Medicus ...

Sunshine Biopharma (SBFM) announced the appointment of Michel Roy as its new Chief Commercial Officer, effective immediately. In this role, Roy will be responsible for overseeing the Company’s ...

After hours: January 17 at 7:59:09 PM EST Loading Chart for STRO ...

After hours: January 16 at 5:36:41 PM EST Loading Chart for CUE ...

Deep Dive: AI 2024 In this issue, we delve into the transformative impact of AI on healthcare and pharma, featuring insights on key AI trends from the floor of Frontiers Health, the ongoing battle ...

Following the strange year for the biopharma industry that was 2024, insiders and analysts alike are waiting expectantly to see how trends in layoffs, drug shortages, clinical trials and more play ...

Here, we highlight the trends and key deals. The transactions analysed include those in the biopharma industry, as well as consumer and over-the-counter companies, drug delivery technologies ...

Axios' Eleanor Hawkins speaking with PhRMA CEO Stephen Ubl in San Francisco. Photo: Chris Constantine on behalf of Axios ...